drugset / Trial / NCT07315139
Pentoxifylline on Inflammatory Markers in Non-Diabetic Chronic Kidney Disease Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
This study aimed to determine the impact of Pentoxifylline on inflammatory biomarkers and the progression of chronic kidney disease in non-diabetic patients.
Timeline
- Start
- 2023-02-01
- Primary completion
- 2023-08-31
- Completion
- 2023-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pentoxifylline | Small molecule | 400 mg | — |
| Comparator | Ramipril | Small molecule | 1.25 mg | — |